Once viewed as an inevitable consequence of aging, cardiovasculardisease is now known to be related to modifiable risk factors,especially smoking, elevated blood pressure, and elevated cholesterol.Numerous preventive interventions have been developed in recentdecades to combat these risk factors. The issue now is how bestto allocate resources among these interventions in order toprevent disease.
Antihypertensive drugs, for example, though effective, varywidely in their cost effectiveness. Propranolol costs $20,000to save a year of life (life-year) for adults 35 to 64 yearsof age, and captopril costs $130,0001 (the medical componentof the Consumer Price . . . [Full Text of this Article]
References
This article has been cited by other articles:
Tice, J. A., Ross, E., Coxson, P. G., Rosenberg, I., Weinstein, M. C., Hunink, M. G. M., Goldman, P. A., Williams, L., Goldman, L.
(2001). Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond. JAMA
286: 936-943
[Abstract][Full Text]
Goldman, L., Coxson, P., Hunink, M. G. M., Goldman, P. A., Tosteson, A. N. A., Mittleman, M., Williams, L., Weinstein, M. C.
(1999). The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. J Am Coll Cardiol
34: 768-776
[Abstract][Full Text]
Redberg, R. F., Gaenzer, H., Neumayr, G., Patsch, J. R., Daviglus, M. L., Liu, K., Greenland, P., Stamler, J., Russell, L. B.
(1999). Cardiovascular Risk Factors and Medicare Costs. NEJM
340: 813-814
[Full Text]
Rowe, J. W.
(1999). Geriatrics, Prevention, and the Remodeling of Medicare. NEJM
340: 720-721
[Full Text]